Niel Hens received a master degree in mathematics (1999) from KU Leuven and a master of science and a PhD degree in biostatistics (2005) from Hasselt University. Since 2009 he is holder of the chair of evidence-based vaccinology at the University of Antwerp. He published work at the intersection between statistics and mathematical epidemiology focussing on semi-and non-parametric methods for handling missing data in his PhD work and after mainly focussing on bridging the gap between mathematical and statistical methods in infectious disease epidemiology. Next to biostatistics, Niel Hens teaches courses on computational biology and mathematical epidemiology to master of statistics and master of epidemiology students both in Antwerp and Hasselt. He is frequently consulted by federal and Flemish authorities especially for health-related topics. He is former co-president of the young academy of Belgium.
He/him/his
Belgium
Juga AJC, Hens N, Osman N, Aerts M. (2026). Joint modelling of left- and interval-censored viral load for couples in Mozambique. PloS one, 21(3)
Mazzoli M, Varela-Lasheras I, Namorado S, Pereira Caetano C, Leite A, Hermans L, Hens N, Türkmen P, Kalimeri K, Ferres L, Cattuto C, Paolotti D, Verhulst S. (2026). Nontraditional Data in Pandemic Preparedness and Response: Identifying and Addressing First- and Last-Mile Challenges. Journal of medical Internet research, (28)
Bagaforo RJ, Dupas MC, Abrams S, Dellicour S, Hens N. (2026). A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned. Archives of public health = Archives belges de sante publique, 84(1)
Furquim d'Almeida A, Ho E, Beutels P, Maertens K, Hens N, Van Damme P, Theeten H, Vanwolleghem T. (2026). Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey. BMC infectious diseases
Aloni R, Hens N, Reddy T. (2026). Endemic-epidemic modeling of the COVID-19 pandemic in South Africa. BMC infectious diseases
Wambua J, Lang JC, Ogunjimi B, Hens N, Beutels P. (2026). Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms. PloS one, 21(3)
De Weerdt L, Thiriard A, Vu Duc I, Reviya N, Van Damme P, Hens N, Marchant A, Maertens K. (2026). Timing of maternal Tdap vaccination: A dynamic balance between antibody induction and placental transfer efficiency. Vaccine, (88)
Cimpean A, Verstraeten T, Willem L, Hens N, Nowé A, Libin P. (2026). Evaluating COVID-19 vaccine allocation policies using Bayesian m-top exploration. Scientific reports
Kremer C, Hammami N, Cornelissen L, Theeten H, Braeye T, Torneri A, Abrams S, Hens N. (2026). Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 31(22)
Nguyen THT, Hens N, Faes C. (2026). Global mobility flows and COVID-19 spread in Europe during the emergency phase: Insights from Meta-Facebook data. Spatial and spatio-temporal epidemiology, (57)
Miura F, Leung KY, Xiridou M, van Antwerpen M, Low N, Hens N, Vakaniaki EH, Wallinga J. (2026). Dynamic shift in the dominant transmission route of clade Ib monkeypox virus across networks with sexual and nonsexual contacts. Science advances, 12(14)
Furquim d'Almeida A, Ho E, Schüttler C, Beutels P, Hens N, Dudareva S, Van Damme P, Theeten H, Vanwolleghem T. (2026). Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 31(6)
Grosso A, Hens N, Abrams S. (2025). An integrative review of the combined use of mathematical and statistical models for estimating malaria transmission parameters. Malaria journal, 24(1)
Limpoco MAA, Faes C, Hens N. (2025). Federated Mixed Effects Logistic Regression Based on One-Time Shared Summary Statistics. Biometrical journal. Biometrische Zeitschrift, 67(5)
Ward J, Lambert JW, Russell TW, Azam JM, Kucharski AJ, Funk S, Quilty BJ, Gressani O, Hens N, Edmunds WJ. (2025). Estimates of epidemiological parameters for H5N1 influenza in humans: a rapid review. BMC infectious diseases, 25(1)
Coletti P, Hens N, Faes C, McLean HQ, Belongia EA, Rolfes M, Mellis A, Reed C, Biddle J, Kim A, Zhu Y, Talbot HK, Grijalva CG. (2025). The impact of household physical distancing and its timing on the transmission of SARS-CoV-2: Insights from a household transmission evaluation study. Epidemics, (53)
Natalia YA, Molenberghs G, Neyens T, Hens N, Faes C. (2025). Empirical analysis of COVID-19 confirmed cases, hospitalizations, vaccination, and international travel across Belgian provinces in 2021. PloS one, 20(5)
Braeye T, Cornelissen L, Van Cauteren D, van Loenhout JAF, Kremer C, Hens N, Rosas A, Taame A, Blot K, Hammami N. (2025). Belgium's SARS-CoV-2 contact tracing effectively curbed transmission, yet challenges persist in terms of delays, scalability and population adherence. BMC public health, 25(1)
Nguyen THT, Hens N, Faes C. (2025). Capturing the spatiotemporal spread of COVID-19 in 30 European countries during 2020 - 2022. BMC public health, 25(1)
Loedy N, Dorta HG, Abrams S, Crèvecoeur J, Morales DR, Cohet C, Willem L, Molenberghs G, Hens N, Kurz X, Quinten C, Verbeeck J. (2025). An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union. European journal of public health
Kissling E, Nunes B, Hooiveld M, Martínez-Baz I, Monge S, Robertson C, Knol M, Sève N, Mlinarić I, Domegan L, Machado A, Whitaker H, Lazar M, Meijer A, Enkirch T, Casado I, Pérez-Gimeno G, William N, Enouf V, Filipović SK, McKenna A, Rodrigues AP, de Lusignan S, Timnea OC, Latorre-Margalef N, Castilla J, Pozo F, Hamilton M, Masse S, Ilić M, Basile L, O'Donnell J, Guiomar R, Riess M, Popescu RM, Rose AMC, Andrews N, Bacci S, Celentano LP, Valenciano M, Moren A, Beutels P, Hens N, Ecdc Primary Care Study Teams OBOI. (2025). Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study. American journal of epidemiology
Ingelbeen B, van Kleef E, Mbala P, Danis K, Macicame I, Hens N, Cleynen E, van der Sande MAB. (2025). Embedding risk monitoring in infectious disease surveillance for timely and effective outbreak prevention and control. BMJ global health, 10(2)
Loedy N, Hermans L, Bosschaert M, Torneri A, Hens N. (2025). The role of frailty in shaping social contact patterns in Belgium, 2022-2023. Scientific reports, 15(1)
Tsoumanis A, Vanbaelen T, Van Dijck C, Kenyon C, Hens N. (2025). Screening for gonorrhoea and chlamydia: identifying key target populations and intensity-a modelling study of MSM in Belgium. Sexually transmitted infections
Ward J, Gressani O, Kim S, Hens N, Edmunds WJ. (2025). The epidemiology of pathogens with pandemic potential: A review of key parameters and clustering analysis. Epidemics, (54)
Garcia-Fogeda I, Abrams S, Vanhee S, Salloum M, Ogunjimi B, Hens N. (2025). Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo. Vaccine, (64)
Gonzalez Dorta H, Verbeeck J, Crevecoeur J, Morales DR, Loedy N, Cohet C, Willem L, Molenberghs G, Hens N, Kurz X, Quinten C, Abrams S. (2025). Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study. The Lancet. Digital health
Kremer C, Nundu SS, Vakaniaki EH, Brosius I, Mukari G, Munganga P, Bangwen E, Tshomba JC, Mujula Y, De Vos E, Van Dijck C, Houben S, Gressani O, Kacita C, Mukadi-Bamuleka D, Wawina-Bokalanga T, Kinganda-Lusamaki E, Amuri-Aziza A, Lupola PM, Muyembe-Tamfum JJ, Mbala-Kingebeni P, Liesenborghs L, Hens N, Torneri A. (2025). Epidemiological characteristics of monkeypox virus Clade Ib in the Democratic Republic of the Congo. Nature communications
Debie Y, Garcia-Fogeda I, Willem L, Roelant E, Verbruggen L, Vanhoutte G, Croes L, Vulsteke C, Demey W, Lybaert W, Hanssens M, Bols A, Van Ongeval J, De Becker A, Jansens H, Goossens ME, Janssens A, Prenen H, Anguille S, Peeters M, van Dam PA, Hens N, Abrams S, Vandamme T. (2025). Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients. Scientific reports, 15(1)
Manansala R, Bilcke J, Willem L, Hens N, Beutels P. (2025). Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in Belgium. Epidemics, (51)
Angeli L, Caetano CP, Franco N, Coletti P, Faes C, Molenberghs G, Beutels P, Abrams S, Willem L, Hens N. (2025). Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis. Nature communications, 16(1)
Gressani O, Hens N. (2025). Nonparametric serial interval estimation with uniform mixtures. PLoS computational biology, 21(8)
Tsoumanis A, Van Dijck C, Hens N, Kenyon C. (2025). Switching From Dual to Monotherapy for Gonorrhea is Associated With a Halving of Gonococcal Resistance to Azithromycin-A Modelling Study of MSM in Belgium. Open forum infectious diseases, 12(6)
Bangwen E, Diavita R, De Vos E, Vakaniaki EH, Nundu SS, Mutombo A, Mulangu F, Abedi AA, Malembi E, Kalonji T, Kacita C, Kinganda-Lusamaki E, Wawina-Bokalanga T, Kremer C, Brosius I, Van Dijck C, Bottieau E, Vercauteren K, Amuri-Aziza A, Makangara-Cigolo JC, Muyamuna E, Pukuta E, Nguete B, Kaba D, Kabamba J, Hughes CM, Tshiani-Mbaya O, Rimoin AW, Hoff NA, Kindrachuk J, Hens N, Peeters M, Low N, McCollum AM, Shongo R, Mukadi-Bamuleka D, Muyembe-Tamfum JJ, Ahuka-Mundeke S, Liesenborghs L, Mbala-Kingebeni P. (2025). Suspected and confirmed mpox cases in DR Congo: a retrospective analysis of national epidemiological and laboratory surveillance data, 2010-23. Lancet, 405(10476)
Vermeulen H, Cuypers L, Catry B, Desmet S, Hens N. (2025). Higher valency vaccines' impact on antimicrobial resistance rates in Streptococcus pneumoniae causing invasive disease: a retrospective analysis based on national reference laboratory data, Belgium, 2018 to 2023. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 30(45)
Varbanova V, Hens N, Beutels P. (2024). Determinants of COVID-19 vaccination coverage in European and Organisation for Economic Co-operation and Development (OECD) countries. Frontiers in public health, (12)
Vermeulen H, Catry B, Catteau L, Hens N. (2024). Community antibiotic consumption in the European Union/European economic area: late-pandemic rebound and seasonality analysis. Archives of public health = Archives belges de sante publique, 82(1)
Besbassi H, Elias G, Meysman P, Jansens H, Laukens K, Damme PV, Hens N, Beutels P, Ogunjimi B. (2024). Modeling antigen-specific T cell dynamics following Hepatitis B Vaccination indicates differences between conventional and regulatory T cell dynamics. Vaccine, 42(21)
Jarvis CI, Coletti P, Backer JA, Munday JD, Faes C, Beutels P, Althaus CL, Low N, Wallinga J, Hens N, Edmunds WJ. (2024). Social contact patterns following the COVID-19 pandemic: a snapshot of post-pandemic behaviour from the CoMix study. Epidemics, (48)
Caetano C, Angeli L, Varela-Lasheras I, Coletti P, Morgado L, Lima P, Willem L, Nunes B, Hens N. (2024). Identifying the main drivers of transmission in the early phase of the COVID-19 pandemic in Portugal. Scientific reports, 14(1)
Sherratt K, Srivastava A, Ainslie K, Singh DE, Cublier A, Marinescu MC, Carretero J, Garcia AC, Franco N, Willem L, Abrams S, Faes C, Beutels P, Hens N, Müller S, Charlton B, Ewert R, Paltra S, Rakow C, Rehmann J, Conrad T, Schütte C, Nagel K, Abbott S, Grah R, Niehus R, Prasse B, Sandmann F, Funk S. (2024). Characterising information gains and losses when collecting multiple epidemic model outputs. Epidemics, (47)
Willem L, Abrams S, Franco N, Coletti P, Libin PJK, Wambua J, Couvreur S, André E, Wenseleers T, Mao Z, Torneri A, Faes C, Beutels P, Hens N. (2024). The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022). BMC public health, 24(1)
De Vos E, Van Gestel L, Brosius I, Kenyon C, Vuylsteke B, De Baetselier I, Mariën J, Bangwen E, Couvreur S, Lecompte A, Van Beckhoven D, Hoorelbeke B, Verstrepen BE, Zaeck LM, de Vries RD, GeurtsvanKessel CH, Hens N, Ariën KK, Vercauteren K, Van Esbroek M, Van Dijck C, Liesenborghs L. (2024). Potential determinants of the decline in mpox cases in Belgium: a behavioral, epidemiological and seroprevalence study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Loedy N, Wallinga J, Hens N, Torneri A. (2024). Repetition in social contacts: implications in modelling the transmission of respiratory infectious diseases in pre-pandemic and pandemic settings. Proceedings. Biological sciences, 291(2027)
Sumalinab B, Gressani O, Hens N, Faes C. (2024). An Efficient Approach to Nowcasting the Time-varying Reproduction Number. Epidemiology (Cambridge, Mass.)
Vanhove MPM, Kmentová N, Faes C, Fernandes JMO, Hahn C, Hens N, Pariselle A, Koblmüller S. (2024). Understanding the Influence of Host Radiation on Symbiont Speciation through Parasites of Species Flocks. Cold Spring Harbor perspectives in biology
Angeli L, Caetano CP, Franco N, Abrams S, Coletti P, Van Nieuwenhuyse I, Pop S, Hens N. (2024). Who acquires infection from whom? A sensitivity analysis of transmission dynamics during the early phase of the COVID-19 pandemic in Belgium. Journal of theoretical biology
Limpoco MAA, Faes C, Hens N. (2024). Linear Mixed Modeling of Federated Data When Only the Mean, Covariance, and Sample Size Are Available. Statistics in medicine
Fajgenblat M, Molenberghs G, Verbeeck J, Willem L, Crèvecoeur J, Faes C, Hens N, Deboosere P, Verbeke G, Neyens T. (2024). Evaluating the direct effect of vaccination and non-pharmaceutical interventions during the COVID-19 pandemic in Europe. Communications medicine, 4(1)
Reichmuth ML, Heron L, Beutels P, Hens N, Low N, Althaus CL. (2024). Social contacts in Switzerland during the COVID-19 pandemic: Insights from the CoMix study. Epidemics, (47)
Braeye T, Proesmans K, Van Cauteren D, Brondeel R, Hens N, Vermeiren E, Hammami N, Rosas A, Taame A, André E, Cuypers L. (2024). Personal characteristics and transmission dynamics associated with SARS-CoV-2 semi-quantitative PCR test results: an observational study from Belgium, 2021-2022. Frontiers in public health, (12)
Bardo M, Hens N, Unkel S. (2024). On the Addams family of discrete frailty distributions for modeling multivariate case I interval-censored data. Biostatistics (Oxford, England)
Gressani O, Torneri A, Hens N, Faes C. (2024). Flexible Bayesian estimation of incubation times. American journal of epidemiology
Boeren M, de Vrij N, Ha MK, Valkiers S, Souquette A, Gielis S, Kuznetsova M, Schippers J, Bartholomeus E, Van den Bergh J, Michels N, Aerts O, Leysen J, Bervoets A, Lambert J, Leuridan E, Wens J, Peeters K, Emonds MP, Elias G, Vandamme N, Jansens H, Adriaensen W, Suls A, Vanhee S, Hens N, Smits E, Van Damme P, Thomas PG, Beutels P, Ponsaerts P, Van Tendeloo V, Delputte P, Laukens K, Meysman P, Ogunjimi B. (2024). Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation. Cell reports, 43(4)
Tsoumanis A, Vanden Berghe W, Hens N, Van Dijck C. (2024). Estimating Partnership Duration among MSM in Belgium-A Modeling Study. Infectious disease reports, 16(3)
Layan M, Hens N, de Hoog MLA, Bruijning-Verhagen PCJL, Cowling BJ, Cauchemez S. (2024). Addressing current limitations of household transmission studies by collecting contact data. American journal of epidemiology
Rozo Posada A, Faes C, Beutels P, Pepermans K, Hens N, Van Damme P, Neyens T. (2024). The effect of spatio-temporal sample imbalance in epidemiologic surveillance using opportunistic samples: An ecological study using real and simulated self-reported COVID-19 symptom data. Spatial and spatio-temporal epidemiology, (50)
Ensoy-Musoro C, Nguyen MH, Hens N, Molenberghs G, Faes C. (2023). Spatio-temporal model to investigate COVID-19 spread accounting for the mobility amongst municipalities. Spatial and spatio-temporal epidemiology, (45)
Tsoumanis A, Van Dijck C, Hens N, Kenyon C. (2023). Rethinking Screening Intensity in Terms of Reducing Prevalence or Increasing Selection Pressure for the Emergence of Resistant Gonorrhea: A Modeling Study of Men Who Have Sex With Men in Belgium. Open forum infectious diseases, 10(4)
de Meijere G, Valdano E, Castellano C, Debin M, Kengne-Kuetche C, Turbelin C, Noël H, Weitz JS, Paolotti D, Hermans L, Hens N, Colizza V. (2023). Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study. The Lancet regional health. Europe, (28)
Backer JA, Bogaardt L, Beutels P, Coletti P, Edmunds WJ, Gimma A, van Hagen CCE, Hens N, Jarvis CI, Vos ERA, Wambua J, Wong D, van Zandvoort K, Wallinga J. (2023). Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands. Scientific reports, 13(1)
Wong KLM, Gimma A, Coletti P, , Faes C, Beutels P, Hens N, Jaeger VK, Karch A, Johnson H, Edmunds W, Jarvis CI. (2023). Social contact patterns during the COVID-19 pandemic in 21 European countries - evidence from a two-year study. BMC infectious diseases, 23(1)
Nguyen MH, Nguyen THT, Molenberghs G, Abrams S, Hens N, Faes C. (2023). The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021. BMC infectious diseases, 23(1)
Kremer C, Kamali A, Kuteesa M, Seeley J, Hens N, Nsubuga RN. (2023). Modelling the impact of combining HIV prevention interventions on HIV dynamics in fishing communities in Uganda. BMC infectious diseases, 23(1)
Kremer C, Willem L, Boone J, Arrazola de Oñate W, Hammami N, Faes C, Hens N. (2023). Key performance indicators of COVID-19 contact tracing in Belgium from September 2020 to December 2021. PloS one, 18(10)
Mao Z, Li X, Dacosta-Urbieta A, Billard MN, Wildenbeest J, Korsten K, Martinón-Torres F, Heikkinen T, Cunningham S, Snape MD, Robinson H, Pollard AJ, Postma M, Dervaux B, Hens N, Bont L, Bilcke J, Beutels P, . (2023). Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe. Vaccine, 41(16)
Vandendijck Y, Gressani O, Faes C, Camarda CG, Hens N. (2023). Cohort-based smoothing methods for age-specific contact rates. Biostatistics (Oxford, England)
Tizzani M, De Gaetano A, Jarvis CI, Gimma A, Wong K, Edmunds WJ, Beutels P, Hens N, Coletti P, Paolotti D. (2023). Impact of tiered measures on social contact and mixing patterns of in Italy during the second wave of COVID-19. BMC public health, 23(1)
Kremer C, Torneri A, Libin PJK, Meex C, Hayette MP, Bontems S, Durkin K, Artesi M, Bours V, Lemey P, Darcis G, Hens N, Meuris C. (2023). Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data. Epidemics, (44)
Besbassi H, Garcia-Fogeda I, Quinlivan M, Breuer J, Abrams S, Hens N, Ogunjimi B, Beutels P. (2023). Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies. Frontiers in immunology, (14)
Gressani O, Faes C, Hens N. (2023). An approximate Bayesian approach for estimation of the instantaneous reproduction number under misreported epidemic data. Biometrical journal. Biometrische Zeitschrift, 65(6)
Wambua J, Loedy N, Jarvis CI, Wong KLM, Faes C, Grah R, Prasse B, Sandmann F, Niehus R, Johnson H, Edmunds WJ, Beutels P, Hens N, Coletti P. (2023). The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study. BMC public health, 23(1)
Møgelmose S, Neels K, Beutels P, Hens N. (2023). Exploring the impact of population ageing on the spread of emerging respiratory infections and the associated burden of mortality. BMC infectious diseases, 23(1)
Varbanova V, Hens N, Beutels P. (2023). Determinants of life-expectancy and disability-adjusted life years (DALYs) in European and Organisation for Economic Co-operation and Development (OECD) countries: A longitudinal analysis (1990-2019). SSM - population health, (24)
Loedy N, Coletti P, Wambua J, Hermans L, Willem L, Jarvis CI, Wong KLM, Edmunds WJ, Robert A, Leclerc QJ, Gimma A, Molenberghs G, Beutels P, Faes C, Hens N. (2023). Longitudinal social contact data analysis: insights from 2 years of data collection in Belgium during the COVID-19 pandemic. BMC public health, 23(1)
Vermeulen H, Hens N, Catteau L, Catry B, Coenen S. (2023). Impact of the COVID-19 pandemic on community antibiotic consumption in the EU/European Economic Area: a changepoint analysis. The Journal of antimicrobial chemotherapy
Devleesschauwer B, Willem L, Jurčević J, Smith P, Scohy A, Wyper GMA, Pires SM, Van Goethem N, Beutels P, Franco N, Abrams S, Van Cauteren D, Speybroeck N, Hens N, De Pauw R. (2023). The direct disease burden of COVID-19 in Belgium in 2020 and 2021. BMC public health, 23(1)
Jit M, Ainslie K, Althaus C, Caetano C, Colizza V, Paolotti D, Beutels P, Willem L, Edmunds J, Nunes B, Namorado S, Faes C, Low N, Wallinga J, Hens N. (2023). Reflections On Epidemiological Modeling To Inform Policy During The COVID-19 Pandemic In Western Europe, 2020-23. Health affairs (Project Hope), 42(12)
Møgelmose S, Vijnck L, Neven F, Neels K, Beutels P, Hens N. (2023). Population age and household structures shape transmission dynamics of emerging infectious diseases: a longitudinal microsimulation approach. Journal of the Royal Society, Interface, 20(209)
Nguyen THT, Nguyen TV, Luong QC, Ho TV, Faes C, Hens N. (2022). Understanding the transmission dynamics of a large-scale measles outbreak in Southern Vietnam. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (122)
Bruyndonckx R, Bilcke J, van der Velden AW, Li X, Hens N, Coenen S, Butler CC, Beutels P. (2022). Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(2)
Molenberghs G, Faes C, Verbeeck J, Deboosere P, Abrams S, Willem L, Aerts J, Theeten H, Devleesschauwer B, Bustos Sierra N, Renard F, Herzog S, Lusyne P, Van der Heyden J, Van Oyen H, Van Damme P, Hens N. (2022). COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(7)
Franco N, Coletti P, Willem L, Angeli L, Lajot A, Abrams S, Beutels P, Faes C, Hens N. (2022). Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data. PLoS computational biology, 18(3)
Reichmuth ML, Hodcroft EB, Riou J, Neher RA, Hens N, Althaus CL. (2022). Impact of cross-border-associated cases on the SARS-CoV-2 epidemic in Switzerland during summer 2020 and 2021. Epidemics, (41)
Herzog SA, De Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, Coppens A, De Spiegeleer S, Beutels P, Van Damme P, Hens N, Theeten H. (2022). Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(9)
Varbanova V, Verelst F, Hens N, Beutels P. (2022). Determinants of basic childhood vaccination coverage in European and OECD countries. Human vaccines & immunotherapeutics
Wambua J, Munywoki PK, Coletti P, Nyawanda BO, Murunga N, Nokes DJ, Hens N. (2022). Drivers of respiratory syncytial virus seasonal epidemics in children under 5 years in Kilifi, coastal Kenya. PloS one, 17(11)
Wambua J, Hermans L, Coletti P, Verelst F, Willem L, Jarvis CI, Gimma A, Wong KLM, Lajot A, Demarest S, Edmunds WJ, Faes C, Beutels P, Hens N. (2022). The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic. Scientific reports, 12(1)
Busschots D, Kremer C, Bielen R, Koc ÖM, Heyens L, Nevens F, Hens N, Robaeys G. (2022). Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis. BMC public health, 22(1)
Drolet M, Godbout A, Mondor M, Béraud G, Drolet-Roy L, Lemieux-Mellouki P, Bureau A, Demers É, Boily MC, Sauvageau C, De Serres G, Hens N, Beutels P, Dervaux B, Brisson M. (2022). Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study. BMC public health, 22(1)
Kuylen EJ, Torneri A, Willem L, Libin PJK, Abrams S, Coletti P, Franco N, Verelst F, Beutels P, Liesenborgs J, Hens N. (2022). Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2. PLoS computational biology, 18(8)
Hoang TV, Willem L, Coletti P, Van Kerckhove K, Minnen J, Beutels P, Hens N. (2022). Exploring human mixing patterns based on time use and social contact data and their implications for infectious disease transmission models. BMC infectious diseases, 22(1)
Møgelmose S, Neels K, Hens N. (2022). Incorporating human dynamic populations in models of infectious disease transmission: a systematic review. BMC infectious diseases, 22(1)
Gressani O, Faes C, Hens N. (2022). Laplacian-P-splines for Bayesian inference in the mixture cure model. Statistics in medicine, 41(14)
Merckx J, Crèvecoeur J, Proesmans K, Hammami N, Denys H, Hens N. (2022). COVID-19 surveillance in the Flemish school system: development of systematic data collection within the public health school system and descriptive analysis of cases reported between October 2020 and June 2021. BMC public health, 22(1)
Crèvecoeur J, Hens N, Neyens T, Larivière Y, Verhasselt B, Masson H, Theeten H. (2022). Change in COVID19 outbreak pattern following vaccination in long-term care facilities in Flanders, Belgium. Vaccine
Mao Z, Li X, Korsten K, Bont L, Butler C, Wildenbeest J, Coenen S, Hens N, Bilcke J, Beutels P, . (2022). Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older Adults. The Journal of infectious diseases, 226(Suppl 1)
Nguyen THT, Faes C, Hens N. (2022). Measles epidemic in Southern Vietnam: An age-stratified spatio-temporal model for infectious disease counts. Epidemiology and infection
Vranckx M, Faes C, Molenberghs G, Hens N, Beutels P, Van Damme P, Aerts J, Petrof O, Pepermans K, Neyens T. (2022). A spatial model to jointly analyze self-reported survey data of COVID-19 symptoms and official COVID-19 incidence data. Biometrical journal. Biometrische Zeitschrift
Gressani O, Wallinga J, Althaus CL, Hens N, Faes C. (2022). EpiLPS: A fast and flexible Bayesian tool for estimation of the time-varying reproduction number. PLoS computational biology, 18(10)
Wong KLM, Gimma A, Paixao ES, , Faes C, Beutels P, Hens N, Jarvis CI, Edmunds WJ. (2022). Pregnancy during COVID-19: social contact patterns and vaccine coverage of pregnant women from CoMix in 19 European countries. BMC pregnancy and childbirth, 22(1)
Okello G, Izudi J, Ampeire I, Nghania F, Dochez C, Hens N. (2022). Two decades of regional trends in vaccination completion and coverage among children aged 12-23 months: an analysis of the Uganda Demographic Health Survey data from 1995 to 2016. BMC health services research, 22(1)
Silva B, Hens N, Gusso G, Lagaert S, Macinko J, Willems S. (2022). Dual Use of Public and Private Health Care Services in Brazil. International journal of environmental research and public health, 19(3)
Peeters M, Schenk J, De Somer T, Roskams T, Locus T, Klamer S, Subissi L, Suin V, Delwaide J, Stärkel P, De Maeght S, Willems P, Colle I, Van Hoof M, Van Acker J, Van Steenkiste C, Moreno C, Janssens F, Reynders M, Steverlynck M, Verlinden W, Lasser L, de Galocsy C, Geerts A, Maus J, Gallant M, Van Outryve S, Marot A, Reynaert H, Decaestecker J, Bottieau E, Schreiber J, Mulkay JP, de Goeij S, Salame M, Dooremont D, Dastis SN, Boes J, Nijs J, Beyls J, Hens N, Nevens F, Van Gucht S, Vanwolleghem T, . (2022). Viral clade is associated with severity of symptomatic genotype 3 Hepatitis E virus infections in Belgium, 2010-2018. Journal of hepatology
Torneri A, Willem L, Colizza V, Kremer C, Meuris C, Darcis G, Hens N, Libin PJK. (2022). Controlling SARS-CoV-2 in schools using repetitive testing strategies. eLife, (11)
Avonts M, Michels NR, Bombeke K, Hens N, Coenen S, Vanderveken OM, De Winter BY. (2022). Does peer teaching improve academic results and competencies during medical school? A mixed methods study. BMC medical education, 22(1)
Tsuzuki S, Asai Y, Ibuka Y, Nakaya T, Ohmagari N, Hens N, Beutels P. (2022). Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games. Journal of global health, (12)
Van Dijck C, Hens N, Kenyon C, Tsoumanis A. (2022). The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium. A modelling study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Yin N, Dellicour S, Daubie V, Franco N, Wautier M, Faes C, Van Cauteren D, Nymark L, Hens N, Gilbert M, Hallin M, Vandenberg O. (2021). Leveraging of SARS-CoV-2 PCR Cycle Thresholds Values to Forecast COVID-19 Trends. Frontiers in medicine, (8)
Valckx S, Crèvecoeur J, Verelst F, Vranckx M, Hendrickx G, Hens N, Van Damme P, Pepermans K, Beutels P, Neyens T. (2021). Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020). Vaccine
Darcis G, Meuris C, Kremer C, Faes C, Hens N. (2021). The risk of underestimating the contribution of children to SARS-CoV-2 pandemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Coletti P, Libin P, Petrof O, Willem L, Abrams S, Herzog SA, Faes C, Kuylen E, Wambua J, Beutels P, Hens N. (2021). A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies. BMC infectious diseases, 21(1)
Verelst F, Hermans L, Vercruysse S, Gimma A, Coletti P, Backer JA, Wong KLM, Wambua J, van Zandvoort K, Willem L, Bogaardt L, Faes C, Jarvis CI, Wallinga J, Edmunds WJ, Beutels P, Hens N. (2021). SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries. BMC medicine, 19(1)
Torneri A, Libin P, Scalia Tomba G, Faes C, Wood JG, Hens N. (2021). On realized serial and generation intervals given control measures: The COVID-19 pandemic case. PLoS computational biology, 17(3)
Libin PJK, Willem L, Verstraeten T, Torneri A, Vanderlocht J, Hens N. (2021). Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics. PLoS computational biology, 17(3)
Boey L, Roelants M, Merckx J, Hens N, Desombere I, Duysburgh E, Vandermeulen C. (2021). Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission. European journal of pediatrics
Busschots D, Kremer C, Bielen R, Koc ÖM, Heyens L, Brixko C, Laukens P, Orlent H, Bilaey P, De Smet F, Hellemans G, Muyldermans G, Van Baelen L, Hens N, Van Vlierberghe H, Robaeys G. (2021). A multicentre interventional study to assess blood-borne viral infections in Belgian prisons. BMC infectious diseases, 21(1)
Adriaenssens N, Bruyndonckx R, Versporten A, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Quality appraisal of antibiotic consumption in the community, European Union/European Economic Area, 2009 and 2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Versporten A, Bruyndonckx R, Adriaenssens N, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Adriaenssens N, Bruyndonckx R, Versporten A, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Consumption of quinolones in the community, European Union/European Economic Area, 1997-2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Bruyndonckx R, Adriaenssens N, Hens N, Versporten A, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Consumption of penicillins in the community, European Union/European Economic Area, 1997-2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Adriaenssens N, Bruyndonckx R, Versporten A, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Versporten A, Bruyndonckx R, Adriaenssens N, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Bruyndonckx R, Adriaenssens N, Versporten A, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017: data collection, management and analysis. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Bruyndonckx R, Adriaenssens N, Versporten A, Hens N, Monnet DL, Molenberghs G, Goossens H, Weist K, Coenen S, . (2021). Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Bruyndonckx R, Hoxha A, Quinten C, Ayele GM, Coenen S, Versporten A, Adriaenssens N, Muller A, Heuer O, Monnet DL, Goossens H, Molenberghs G, Weist K, Hens N, . (2021). Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997-2017. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Bruyndonckx R, Coenen S, Adriaenssens N, Versporten A, Monnet DL, Goossens H, Molenberghs G, Weist K, Hens N, . (2021). Analysing the trend over time of antibiotic consumption in the community: a tutorial on the detection of common change-points. The Journal of antimicrobial chemotherapy, 76(Supplement_2)
Verbeeck J, Faes C, Neyens T, Hens N, Verbeke G, Deboosere P, Molenberghs G. (2021). A linear mixed model to estimate COVID-19-induced excess mortality. Biometrics
Orije MRP, García-Fogeda I, Van Dyck W, Corbière V, Mascart F, Mahieu L, Hens N, Van Damme P, Cools N, Ogunjimi B, Maertens K, Leuridan E. (2021). Impact of maternal pertussis antibodies on the infants' cellular immune responses. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, Giordano G, Hanson C, Hens N, Iftekhar E, Klimek P, Kretzschmar M, Peichl A, Perc M, Sannino F, Schernhammer E, Schmidt A, Staines A, Szczurek E. (2021). Call for a pan-European COVID-19 response must be comprehensive - Authors' reply. Lancet, 397(10284)
Abrams S, Wambua J, Santermans E, Willem L, Kuylen E, Coletti P, Libin P, Faes C, Petrof O, Herzog SA, Beutels P, Hens N. (2021). Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories. Epidemics, (35)
Verelst F, Beutels P, Hens N, Willem L. (2021). Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective. Vaccine
Driessche KV, Mahlobo PZ, Venter R, Caldwell J, Jennings K, Diacon AH, Cotton MF, de Groot R, Hens N, Marx FM, Warren RM, Mishra H, Theron G. (2021). Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?. The Lancet. Respiratory medicine
Hendrickx DM, Sousa JD, Libin PJK, Delva W, Liesenborgs J, Hens N, Müller V, Vandamme AM. (2021). Comparison of two simulators for individual based models in HIV epidemiology in a population with HSV 2 in Yaoundé (Cameroon). Scientific reports, 11(1)
Busschots D, Kremer C, Koc ÖM, Heyens L, Bielen R, Apers L, Florence E, Messiaen P, Van Laethem K, Van Wijngaerden E, Nevens F, Hens N, Robaeys G. (2021). The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Hoang TV, Coletti P, Kifle YW, Kerckhove KV, Vercruysse S, Willem L, Beutels P, Hens N. (2021). Close contact infection dynamics over time: insights from a second large-scale social contact survey in Flanders, Belgium, in 2010-2011. BMC infectious diseases, 21(1)
Van Wilder L, Charafeddine R, Beutels P, Bruyndonckx R, Cleemput I, Demarest S, De Smedt D, Hens N, Scohy A, Speybroeck N, Van der Heyden J, Yokota RTC, Van Oyen H, Bilcke J, Devleesschauwer B. (2021). Belgian population norms for the EQ-5D-5L, 2018. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Busschots D, Kremer C, Bielen R, Koc ÖM, Heyens L, Dercon E, Verrando R, Windelinckx T, Maertens G, Bourgeois S, Hens N, Matheï C, Robaeys G. (2021). Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium. Harm reduction journal, 18(1)
Faes C, Hens N, Gilbert M. (2021). On the timing of interventions to preserve hospital capacity: lessons to be learned from the Belgian SARS-CoV-2 pandemic in 2020. Archives of public health = Archives belges de sante publique, 79(1)
Heireman L, Abrams S, Bruynseels P, Cartuyvels R, Cuypers L, De Schouwer P, Laffut W, Lagrou K, Hens N, Ho E, Padalko E, Reynders M, Vandamme S, Van der Moeren N, Verstrepen W, Willems P, Naesens R. (2021). Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium. PloS one, 16(11)
Maertens K, Orije MRP, Herzog SA, Mahieu LM, Hens N, Van Damme P, Leuridan E. (2021). Pertussis immunization during pregnancy: assessment of the role of maternal antibodies on immune responses in term and preterm born infants. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Hendrickx DM, Delva W, Hens N. (2021). Influence of sexual risk behaviour and STI co-infection dynamics on the evolution of HIV set point viral load in MSM. Epidemics, (36)
Vermeulen H, Coenen S, Hens N, Bruyndonckx R. (2021). Impact of changing reimbursement criteria on the use of fluoroquinolones in Belgium. The Journal of antimicrobial chemotherapy
Koc ÖM, De Smedt P, Kremer C, Robaeys G, Van Damme P, Hens N, Almeida J, Falkenberg F, Savelkoul P, Oude Lashof A, . (2021). Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: double-blinded, randomised, controlled phase 2 trial. Liver international : official journal of the International Association for the Study of the Liver
Willem L, Abrams S, Libin PJK, Coletti P, Kuylen E, Petrof O, Møgelmose S, Wambua J, Herzog SA, Faes C, Beutels P, Hens N. (2021). The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19. Nature communications, 12(1)
Kremer C, Torneri A, Boesmans S, Meuwissen H, Verdonschot S, Vanden Driessche K, Althaus CL, Faes C, Hens N. (2021). Quantifying superspreading for COVID-19 using Poisson mixture distributions. Scientific reports, 11(1)
Bruyndonckx R, Stuart B, Little P, Hens N, Ieven M, Butler CC, Verheij TJM, Goossens H, Coenen S, The Grace Project Group. (2021). The Effect of Amoxicillin in Adult Patients Presenting to Primary Care with Acute Cough Predicted to Have Pneumonia or a Combined Viral-Bacterial Infection. Antibiotics (Basel, Switzerland), 10(7)
Tran TMP, Abrams S, Aerts M, Maertens K, Hens N. (2021). Measuring association among censored antibody titer data. Statistics in medicine
Meuris C, Kremer C, Geerinck A, Locquet M, Bruyère O, Defêche J, Meex C, Hayette MP, Duchene L, Dellot P, Azarzar S, Maréchal N, Sauvage AS, Frippiat F, Giot JB, Léonard P, Fombellida K, Moutschen M, Durkin K, Artesi M, Bours V, Faes C, Hens N, Darcis G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA network open, 4(10)
Hens N, Vranck P, Molenberghs G. (2020). The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions. European heart journal. Acute cardiovascular care, 9(3)
Schenk J, Abrams S, Theeten H, Van Damme P, Beutels P, Hens N. (2020). Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis. The Lancet. Infectious diseases
Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J, Hens N. (2020). Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(17)
Neyens T, Faes C, Vranckx M, Pepermans K, Hens N, Van Damme P, Molenberghs G, Aerts J, Beutels P. (2020). Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?. Spatial and spatio-temporal epidemiology, (35)
Quarta A, Meese T, Pieters Z, Van Breedam E, Le Blon D, Van Broeckhoven J, Hendrix S, Goossens H, Hens N, Berneman Z, Van Nieuwerburgh F, Ponsaerts P. (2020). Murine induced pluripotent stem cell-derived neuroimmune cell culture models emphasize opposite immune-effector functions of interleukin 13-primed microglia and macrophages in terms of neuroimmune toxicity. Glia
Kremer C, Ganyani T, Chen D, Torneri A, Faes C, Wallinga J, Hens N. (2020). Authors' response: Estimating the generation interval for COVID-19 based on symptom onset data. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(29)
Abu-Raya B, Migliori GB, O'Ryan M, Edwards K, Torres A, Alffenaar JW, Märtson AG, Centis R, D'Ambrosio L, Flanagan K, Hung I, Lauretani F, Leung CC, Leuridan E, Maertens K, Maggio MG, Nadel S, Hens N, Niesters H, Osterhaus A, Pontali E, Principi N, Rossato Silva D, Omer S, Spanevello A, Sverzellati N, Tan T, Torres-Torreti JP, Visca D, Esposito S. (2020). Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Frontiers in medicine, (7)
Koc ÖM, Kremer C, Hens N, Bielen R, Busschots D, Van Damme P, Robaeys G. (2020). Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium. PloS one, 15(7)
Wijtvliet VPWM, Plaeke P, Abrams S, Hens N, Gielis EM, Hellemans R, Massart A, Hesselink DA, De Winter BY, Abramowicz D, Ledeganck KJ. (2020). Donor-derived cell-free dna as a biomarker for rejection after kidney transplantation: A systematic review and meta-analysis. Transplant international : official journal of the European Society for Organ Transplantation
Torneri A, Libin P, Vanderlocht J, Vandamme AM, Neyts J, Hens N. (2020). A prospect on the use of antiviral drugs to control local outbreaks of COVID-19. BMC medicine, 18(1)
Bruyndonckx R, Coenen S, Butler C, Verheij T, Little P, Hens N, Beutels P, Ieven M, Goossens H, . (2020). Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (95)
Mugenyi L, Nankabirwa JI, Arinaitwe E, Rek J, Hens N, Kamya M, Dorsey G. (2020). Estimating the optimal interval between rounds of indoor residual spraying of insecticide using malaria incidence data from cohort studies. PloS one, 15(10)
Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, Giordano G, Gurdasani D, Hanson C, Hens N, Iftekhar E, Kelly-Irving M, Klimek P, Kretzschmar M, Peichl A, Perc M, Sannino F, Schernhammer E, Schmidt A, Staines A, Szczurek E. (2021). Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. Lancet, 397(10269)
Ho E, Schenk J, Hutse V, Suin V, Litzroth A, Blaizot S, Herzog SA, Verburgh V, Jacques M, Rahman A, Michielsen P, Van Damme P, Van Gucht S, Theeten H, Hens N, Vanwolleghem T. (2020). Stable HEV IgG seroprevalence in Belgium between 2006 and 2014. Journal of viral hepatitis
Faes C, Abrams S, Van Beckhoven D, Meyfroidt G, Vlieghe E, Hens N, . (2020). Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients. International journal of environmental research and public health, 17(20)
Willem L, Van Hoang T, Funk S, Coletti P, Beutels P, Hens N. (2020). SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19. BMC research notes, 13(1)
Juga AJC, Hens N, Osman N, Aerts M. (2020). Factors associated with HIV serodiscordance among couples in Mozambique: Comparison of the 2009 INSIDA and 2015 IMASIDA surveys. PloS one, 15(6)
Coletti P, Wambua J, Gimma A, Willem L, Vercruysse S, Vanhoutte B, Jarvis CI, Van Zandvoort K, Edmunds J, Beutels P, Hens N. (2020). CoMix: comparing mixing patterns in the Belgian population during and after lockdown. Scientific reports, 10(1)
Tran TMP, Maertens K, Hoang HTT, Van Damme P, Leuridan E, Hens N. (2020). Elucidating the difference in the kinetics of antibody titres of infants in Belgium and Vietnam. Vaccine
Kuylen E, Willem L, Broeckhove J, Beutels P, Hens N. (2020). Clustering of susceptible individuals within households can drive measles outbreaks: an individual-based model exploration. Scientific reports, 10(1)
Molenberghs G, Buyse M, Abrams S, Hens N, Beutels P, Faes C, Verbeke G, Van Damme P, Goossens H, Neyens T, Herzog S, Theeten H, Pepermans K, Abad AA, Van Keilegom I, Speybroeck N, Legrand C, De Buyser S, Hulstaert F. (2020). Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country. Contemporary clinical trials, (99)
Willem Lander, Hoang Thang Va, Funk Sebastian, Coletti Pietro, Beutels Philippe, Hens Niel. (2020). SOCRATES: An online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19. Cold Spring Harbor Laboratory Press
Ganyani Tapiwa, Kremer Cecile, Chen Dongxuan, Torneri Andrea, Faes Christel, Wallinga Jacco, Hens Niel. (2020). Estimating the generation interval for COVID-19 based on symptom onset data. Cold Spring Harbor Laboratory Press
Hendrickx DM, Abrams S, Hens N. (2019). The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation. Journal of theoretical biology, (476)
Pham TV, Nguyen HV, Aguirre AR, Nguyen VV, A Cleves M, Nguyen XX, Nguyen TT, Tran DT, Le HX, Hens N, Rosanas-Urgell A, D'Alessandro U, Speybroeck N, Erhart A. (2019). Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam. PLoS medicine, 16(5)
Vanlinthout LE, Geniets B, Driessen JJ, Saldien V, Lapré R, Berghmans J, Uwimpuhwe G, Hens N. (2020). Neuromuscular-blocking agents for tracheal intubation in pediatric patients (0-12 years): A systematic review and meta-analysis. Paediatric anaesthesia, 30(4)
Ganyani T, Faes C, Hens N. (2020). Inference of the generalized-growth model via maximum likelihood estimation: A reflection on the impact of overdispersion. Journal of theoretical biology, (484)
Koc ÖM, Hens N, Bielen R, Van Damme P, Robaeys G. (2019). Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening. Medicine, 98(18)
Bannister-Tyrrell M, Krit M, Sluydts V, Tho S, Sokny M, Mean V, Kim S, Menard D, Grietens KP, Abrams S, Hens N, Coosemans M, Bassat Q, van Hensbroek MB, Durnez L, Van Bortel W. (2019). Households or Hotspots? Defining Intervention Targets for Malaria Elimination in Ratanakiri Province, Eastern Cambodia. The Journal of infectious diseases, 220(6)
Van Keer S, Willhauck-Fleckenstein M, Pattyn J, Butt J, Tjalma WAA, Van Ostade X, Hens N, Van Damme P, Waterboer T, Vorsters A. (2019). First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, (117)
Braeye T, Quoilin S, Hens N. (2019). Incidence estimation from sentinel surveillance data; a simulation study and application to data from the Belgian laboratory sentinel surveillance. BMC public health, 19(1)
Koc ÖM, Menart C, Theodore J, Kremer C, Hens N, Koek GH, Oude Lashof AML. (2020). Ethnicity and response to primary three-dose hepatitis B vaccination in employees in the Netherlands, 1983 through 2017. Journal of medical virology, 92(3)
Liesenborgs J, Hendrickx DM, Kuylen E, Niyukuri D, Hens N, Delva W. (2019). SimpactCyan 1.0: An Open-source Simulator for Individual-Based Models in HIV Epidemiology with R and Python Interfaces. Scientific reports, 9(1)
Wanlapakorn N, Maertens K, Vongpunsawad S, Puenpa J, Tran TMP, Hens N, Van Damme P, Thiriard A, Raze D, Locht C, Poovorawan Y, Leuridan E. (2020). Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(1)
Quarta A, Le Blon D, D'aes T, Pieters Z, Hamzei Taj S, Miró-Mur F, Luyckx E, Van Breedam E, Daans J, Goossens H, Dewilde S, Hens N, Pasque V, Planas AM, Hoehn M, Berneman Z, Ponsaerts P. (2019). Murine iPSC-derived microglia and macrophage cell culture models recapitulate distinct phenotypical and functional properties of classical and alternative neuro-immune polarisation. Brain, behavior, and immunity, (82)
Koc ÖM, Kremer C, Bielen R, Buscchots D, Hens N, Nevens F, Robaeys G. (2019). Prevalence and risk factors of hepatitis B virus infection in Middle-Limburg Belgium, year 2017: Importance of migration. Journal of medical virology, 91(8)
Derdelinckx J, Mansilla MJ, De Laere M, Lee WP, Navarro-Barriuso J, Wens I, Nkansah I, Daans J, De Reu H, Jolanta Keliris A, Van Audekerke J, Vanreusel V, Pieters Z, Van der Linden A, Verhoye M, Molenberghs G, Hens N, Goossens H, Willekens B, Cras P, Ponsaerts P, Berneman ZN, Martínez-Cáceres EM, Cools N. (2019). Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA. Journal of neuroinflammation, 16(1)
Keersmaekers N, Ogunjimi B, Van Damme P, Beutels P, Hens N. (2019). An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix. Vaccine, 37(19)
Willekens B, Presas-Rodríguez S, Mansilla MJ, Derdelinckx J, Lee WP, Nijs G, De Laere M, Wens I, Cras P, Parizel P, Van Hecke W, Ribbens A, Billiet T, Adams G, Couttenye MM, Navarro-Barriuso J, Teniente-Serra A, Quirant-Sánchez B, Lopez-Diaz de Cerio A, Inogés S, Prosper F, Kip A, Verheij H, Gross CC, Wiendl H, Van Ham MS, Ten Brinke A, Barriocanal AM, Massuet-Vilamajó A, Hens N, Berneman Z, Martínez-Cáceres E, Cools N, Ramo-Tello C, . (2019). Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. BMJ open, 9(9)
Blaizot S, Herzog SA, Abrams S, Theeten H, Litzroth A, Hens N. (2019). Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling. BMC medical research methodology, 19(1)
Hoang T, Coletti P, Melegaro A, Wallinga J, Grijalva CG, Edmunds JW, Beutels P, Hens N. (2019). A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections. Epidemiology (Cambridge, Mass.), 30(5)
Bruyndonckx R, Latour K, Atud GA, Dubovy P, Jaspers S, Hens N, Catry B, Goossens H, Coenen S. (2019). Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients. The Journal of antimicrobial chemotherapy, 74(11)
Béraud G, Abrams S, Beutels P, Dervaux B, Hens N. (2018). Resurgence risk for measles, mumps and rubella in France in 2018 and 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 23(25)
Goeyvaerts N, Santermans E, Potter G, Torneri A, Van Kerckhove K, Willem L, Aerts M, Beutels P, Hens N. (2018). Household members do not contact each other at random: implications for infectious disease modelling. Proceedings. Biological sciences, 285(1893)
Ganyani T, Faes C, Chowell G, Hens N. (2018). Assessing inference of the basic reproduction number in an SIR model incorporating a growth-scaling parameter. Statistics in medicine, 37(29)
De Neuter N, Bartholomeus E, Elias G, Keersmaekers N, Suls A, Jansens H, Smits E, Hens N, Beutels P, Van Damme P, Mortier G, Van Tendeloo V, Laukens K, Meysman P, Ogunjimi B. (2019). Memory CD4(+) T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus. Genes and immunity, 20(3)
Abrams S, Wienke A, Hens N. (2018). Modelling time varying heterogeneity in recurrent infection processes: an application to serological data. Journal of the Royal Statistical Society. Series C, Applied statistics, 67(3)
Kovac T, Haber T, Reeth FV, Hens N. (2018). Heterogeneous computing for epidemiological model fitting and simulation. BMC bioinformatics, 19(1)
Martins A, Aerts M, Hens N, Wienke A, Abrams S. (2018). Correlated gamma frailty models for bivariate survival time data. Statistical methods in medical research, 28(10-11)
Ganyani T, Roosa K, Faes C, Hens N, Chowell G. (2018). Assessing the relationship between epidemic growth scaling and epidemic size: The 2014-16 Ebola epidemic in West Africa. Epidemiology and infection
Bielen R, Kremer C, Koc ÖM, Busschots D, Hendrickx DM, Vanelderen P, Hens N, Nevens F, Robaeys G. (2019). Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium?. Liver international : official journal of the International Association for the Study of the Liver, 39(4)
Bartholomeus E, De Neuter N, Meysman P, Suls A, Keersmaekers N, Elias G, Jansens H, Hens N, Smits E, Van Tendeloo V, Beutels P, Van Damme P, Ogunjimi B, Laukens K, Mortier G. (2018). Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders. Vaccine, 36(42)
Bruyndonckx R, Hens N, Verheij TJ, Aerts M, Ieven M, Butler CC, Little P, Goossens H, Coenen S, . (2018). Development of a prediction tool for patients presenting with acute cough in primary care: a prognostic study spanning six European countries. The British journal of general practice : the journal of the Royal College of General Practitioners, 68(670)
Wanlapakorn N, Maertens K, Chaithongwongwatthana S, Srimuan D, Suratannon N, Vongpunsawad S, Tran TMP, Hens N, Van Damme P, Locht C, Poovorawan Y, Leuridan E. (2018). Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women. Vaccine, 36(11)
Luca G, Kerckhove KV, Coletti P, Poletto C, Bossuyt N, Hens N, Colizza V. (2018). The impact of regular school closure on seasonal influenza epidemics: a data-driven spatial transmission model for Belgium. BMC infectious diseases, 18(1)
Loquiha O, Hens N, Chavane L, Temmerman M, Osman N, Faes C, Aerts M. (2018). Mapping maternal mortality rate via spatial zero-inflated models for count data: A case study of facility-based maternal deaths from Mozambique. PloS one, 13(11)
Beauclair R, Hens N, Delva W. (2018). The role of age-mixing patterns in HIV transmission dynamics: Novel hypotheses from a field study in Cape Town, South Africa. Epidemics, (25)
Ramires TG, Cordeiro GM, Kattan MW, Hens N, Ortega EM. (2018). Predicting the cure rate of breast cancer using a new regression model with four regression structures. Statistical methods in medical research, 27(11)
Aerts M, Juga AJ, Hens N. (2018). Measures for concordance and discordance with applications in disease control and prevention. Statistical methods in medical research, 28(10-11)
Koc ÖM, Robaeys G, Yildirim B, Posthouwer D, Hens N, Koek GH. (2019). The influence of ethnicity on disease outcome in patients with chronic hepatitis B infection. Journal of medical virology, 91(4)
Watson CH, Baker S, Lau CL, Rawalai K, Taufa M, Coriakula J, Thieu NTV, Van TT, Ngoc DTT, Hens N, Lowry JH, de Alwis R, Cano J, Jenkins K, Mulholland EK, Nilles EJ, Kama M, Edmunds WJ. (2017). A cross-sectional seroepidemiological survey of typhoid fever in Fiji. PLoS neglected tropical diseases, 11(7)
Bilcke J, Hens N, Beutels P. (2017). Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 26(8)
Abrams S, Aerts M, Molenberghs G, Hens N. (2017). Parametric overdispersed frailty models for current status data. Biometrics, 73(4)
Bruyndonckx R, Hens N, Aerts M. (2017). Simulation-based evaluation of the linear-mixed model in the presence of an increasing proportion of singletons. Biometrical journal. Biometrische Zeitschrift, 60(1)
Marcq E, Waele J, Audenaerde JV, Lion E, Santermans E, Hens N, Pauwels P, van Meerbeeck JP, Smits ELJ. (2017). Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients. Oncotarget, 8(52)
Herzog SA, Blaizot S, Hens N. (2017). Mathematical models used to inform study design or surveillance systems in infectious diseases: a systematic review. BMC infectious diseases, 17(1)
Michiels B, Nguyen VK, Coenen S, Ryckebosch P, Bossuyt N, Hens N. (2017). Influenza epidemic surveillance and prediction based on electronic health record data from an out-of-hours general practitioner cooperative: model development and validation on 2003-2015 data. BMC infectious diseases, 17(1)
Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, Nozad B, Mirinaviciute G, Flem E, Souverain A, Verstraeten T, Hartwig S. (2017). Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC infectious diseases, 17(1)
Maertens K, Tran TMP, Hens N, Van Damme P, Leuridan E. (2017). Effect of Prepregnancy Pertussis Vaccination in Young Infants. The Journal of infectious diseases, 215(12)
Smit GSA, Padalko E, Van Acker J, Hens N, Dorny P, Speybroeck N, Devleesschauwer B. (2017). Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(4)
Frederix I, Vandijck D, Hens N, De Sutter J, Dendale P. (2018). Economic and social impact of increased cardiac rehabilitation uptake and cardiac telerehabilitation in Belgium - a cost-benefit analysis. Acta cardiologica, 73(3)
Willem L, Verelst F, Bilcke J, Hens N, Beutels P. (2017). Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015). BMC infectious diseases, 17(1)
Martins-Fonteyn E, Loquiha O, Baltazar C, Thapa S, Boothe M, Raimundo I, Hens N, Aerts M, Meulemans H, Degomme O, Wouters E. (2017). Factors influencing risky sexual behaviour among Mozambican miners: a socio-epidemiological contribution for HIV prevention framework in Mozambique. International journal for equity in health, 16(1)
Borremans B, Reijniers J, Hens N, Leirs H. (2017). The shape of the contact-density function matters when modelling parasite transmission in fluctuating populations. Royal Society open science, 4(11)
Juga AJ, Hens N, Osman N, Aerts M. (2017). A flexible method to model HIV serodiscordance among couples in Mozambique. PloS one, 12(3)
Borremans B, Hens N, Beutels P, Leirs H, Reijniers J. (2016). Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife Infections. PLoS computational biology, 12(5)
Santermans E, Van Kerckhove K, Azmon A, John Edmunds W, Beutels P, Faes C, Hens N. (2017). Structural differences in mixing behavior informing the role of asymptomatic infection and testing symptom heritability. Mathematical biosciences, (285)
Marcq E, Siozopoulou V, De Waele J, van Audenaerde J, Zwaenepoel K, Santermans E, Hens N, Pauwels P, van Meerbeeck JP, Smits EL. (2016). Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma. Oncoimmunology, 6(1)
Bertoglio D, Verhaeghe J, Santermans E, Amhaoul H, Jonckers E, Wyffels L, Van Der Linden A, Hens N, Staelens S, Dedeurwaerdere S. (2017). Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbidities. Brain, behavior, and immunity, (61)
Bruyndonckx R, Aerts M, Hens N. (2016). Simulation-based evaluation of the performance of the F test in a linear multilevel model setting with sparseness at the level of the primary unit. Biometrical journal. Biometrische Zeitschrift, 58(5)
Bruyndonckx R, Hens N, Aerts M, Goossens H, Latour K, Catry B, Coenen S. (2017). Persistence of antimicrobial resistance in respiratory streptococci. Journal of global antimicrobial resistance, (8)
Guglielmetti C, Le Blon D, Santermans E, Salas-Perdomo A, Daans J, De Vocht N, Shah D, Hoornaert C, Praet J, Peerlings J, Kara F, Bigot C, Mai Z, Goossens H, Hens N, Hendrix S, Verhoye M, Planas AM, Berneman Z, van der Linden A, Ponsaerts P. (2016). Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages. Glia, 64(12)
Deckx N, Wens I, Nuyts AH, Hens N, De Winter BY, Koppen G, Goossens H, Van Damme P, Berneman ZN, Eijnde BO, Cools N. (2016). 12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis. Mediators of inflammation, (2016)
Braeye T, Verheagen J, Mignon A, Flipse W, Pierard D, Huygen K, Schirvel C, Hens N. (2016). Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance. PloS one, 11(8)
Santermans E, Robesyn E, Ganyani T, Sudre B, Faes C, Quinten C, Van Bortel W, Haber T, Kovac T, Van Reeth F, Testa M, Hens N, Plachouras D. (2016). Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness. PloS one, 11(1)
Abrams S, Kourkouni E, Sabbe M, Beutels P, Hens N. (2016). Inferring rubella outbreak risk from seroprevalence data in Belgium. Vaccine, 34(50)
Maertens K, Hoang TT, Nguyen TD, Caboré RN, Duong TH, Huygen K, Hens N, Van Damme P, Dang DA, Leuridan E. (2016). The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63(suppl 4)
Ogunjimi B, Hens N. (2016). Intradermal zoster vaccines: good for the old and the young?. The Lancet. Infectious diseases, 16(8)
Le Blon D, Guglielmetti C, Hoornaert C, Quarta A, Daans J, Dooley D, Lemmens E, Praet J, De Vocht N, Reekmans K, Santermans E, Hens N, Goossens H, Verhoye M, Van der Linden A, Berneman Z, Hendrix S, Ponsaerts P. (2016). Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model. Journal of neuroinflammation, 13(1)
Vorsters A, Cornelissen T, Leuridan E, Bogers J, Vanden Broeck D, Benoy I, Goossens H, Hens N, Van Damme P. (2016). Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium. BMC public health, (16)
Maertens K, Caboré RN, Huygen K, Vermeiren S, Hens N, Van Damme P, Leuridan E. (2016). Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age. Vaccine, 34(31)
Kifle YW, Goeyvaerts N, Van Kerckhove K, Willem L, Kucharski A, Faes C, Leirs H, Hens N, Beutels P. (2016). Correction: Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases. PloS one, 11(2)
Beauclair R, Helleringer S, Hens N, Delva W. (2016). Age differences between sexual partners, behavioural and demographic correlates, and HIV infection on Likoma Island, Malawi. Scientific reports, (6)
McDonald SA, Devleesschauwer B, Speybroeck N, Hens N, Praet N, Torgerson PR, Havelaar AH, Wu F, Tremblay M, Amene EW, Döpfer D. (2015). Data-driven methods for imputing national-level incidence in global burden of disease studies. Bulletin of the World Health Organization, 93(4)
Vanden Driessche K, Hens N, Tilley P, Quon BS, Chilvers MA, de Groot R, Cotton MF, Marais BJ, Speert DP, Zlosnik JE. (2015). Surgical masks reduce airborne spread of Pseudomonas aeruginosa in colonized patients with cystic fibrosis. American journal of respiratory and critical care medicine, 192(7)
Goeyvaerts N, Willem L, Van Kerckhove K, Vandendijck Y, Hanquet G, Beutels P, Hens N. (2015). Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. Epidemics, (13)
Deckx N, Wens I, Nuyts AH, Lee WP, Hens N, Koppen G, Goossens H, Van Damme P, Berneman ZN, Eijnde BO, Cools N. (2015). Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis. Mediators of inflammation, (2015)
Maertens K, Caboré RN, Huygen K, Hens N, Van Damme P, Leuridan E. (2016). Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study. Vaccine, 34(1)
Goeyvaerts N, Leuridan E, Faes C, Van Damme P, Hens N. (2015). Multi-disease analysis of maternal antibody decay using non-linear mixed models accounting for censoring. Statistics in medicine, 34(20)
Martins-Fonteyn E, Loquiha O, Wouters E, Raimundo I, Hens N, Aerts M, Meulemans H. (2016). HIV Susceptibility Among Migrant Miners in Chokwe: A Case Study. International journal of health services : planning, administration, evaluation, 46(4)
Theeten H, Van Herck K, Van Der Meeren O, Crasta P, Van Damme P, Hens N. (2015). Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions. Vaccine, 33(42)
Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, Van Craenenbroeck E, Van Driessche N, Dendale P. (2016). Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis. European journal of preventive cardiology, 23(7)
Kifle YW, Goeyvaerts N, Van Kerckhove K, Willem L, Kucharski A, Faes C, Leirs H, Hens N, Beutels P. (2015). Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases. PloS one, 10(7)
Beauclair R, Hens N, Delva W. (2015). Concurrent partnerships in Cape Town, South Africa: race and sex differences in prevalence and duration of overlap. Journal of the International AIDS Society, (18)
Lefevere E, Hens N, De Smet F, Beutels P. (2016). The impact of non-financial and financial encouragements on participation in non school-based human papillomavirus vaccination: a retrospective cohort study. The European journal of health economics : HEPAC : health economics in prevention and care, 17(3)
Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, Yazdanpanah Y, Boëlle PY, Hens N, Dervaux B. (2015). The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases. PloS one, 10(7)
Bruyndonckx R, Hens N, Aerts M, Goossens H, Cortiñas Abrahantes J, Coenen S. (2015). Exploring the association between resistance and outpatient antibiotic use expressed as DDDs or packages. The Journal of antimicrobial chemotherapy, 70(4)
Lambert ML, Bruyndonckx R, Goossens H, Hens N, Aerts M, Catry B, Neely F, Vogelaers D, Hammami N. (2015). The Belgian policy of funding antimicrobial stewardship in hospitals and trends of selected quality indicators for antimicrobial use, 1999-2010: a longitudinal study. BMJ open, 5(2)
Ogunjimi B, Willem L, Beutels P, Hens N. (2015). Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster. eLife, (4)
Lefevere E, Theeten H, Hens N, De Smet F, Top G, Van Damme P. (2015). From non school-based, co-payment to school-based, free Human Papillomavirus vaccination in Flanders (Belgium): a retrospective cohort study describing vaccination coverage, age-specific coverage and socio-economic inequalities. Vaccine, 33(39)
Hoang HT, Leuridan E, Maertens K, Nguyen TD, Hens N, Vu NH, Caboré RN, Duong HT, Huygen K, Van Damme P, Dang AD. (2016). Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy. Vaccine, 34(1)
Grijalva CG, Goeyvaerts N, Verastegui H, Edwards KM, Gil AI, Lanata CF, Hens N, . (2015). A household-based study of contact networks relevant for the spread of infectious diseases in the highlands of Peru. PloS one, 10(3)
Willem L, Stijven S, Tijskens E, Beutels P, Hens N, Broeckhove J. (2015). Optimizing agent-based transmission models for infectious diseases. BMC bioinformatics, (16)
Jombart T, Aanensen DM, Baguelin M, Birrell P, Cauchemez S, Camacho A, Colijn C, Collins C, Cori A, Didelot X, Fraser C, Frost S, Hens N, Hugues J, Höhle M, Opatowski L, Rambaut A, Ratmann O, Soubeyrand S, Suchard MA, Wallinga J, Ypma R, Ferguson N. (2014). OutbreakTools: a new platform for disease outbreak analysis using the R software. Epidemics, (7)
Willem L, Stijven S, Vladislavleva E, Broeckhove J, Beutels P, Hens N. (2014). Active learning to understand infectious disease models and improve policy making. PLoS computational biology, 10(4)
Blommaert A, Bilcke J, Vandendijck Y, Hanquet G, Hens N, Beutels P. (2014). Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium. Vaccine, 32(46)
Biermans G, Horemans N, Hens N, Vives i Batlle J, Vandenhove H, Cuypers A. (2014). A dynamic dosimetry model for radioactive exposure scenarios in Arabidopsis thaliana. Journal of theoretical biology, (347)
Bruyndonckx R, Hens N, Aerts M, Goossens H, Molenberghs G, Coenen S. (2014). Measuring trends of outpatient antibiotic use in Europe: jointly modelling longitudinal data in defined daily doses and packages. The Journal of antimicrobial chemotherapy, 69(7)
Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K. (2014). Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults. Vaccine, 32(13)
Coenen S, Bruyndonckx R, Hens N, Aerts M, Goossens H. (2014). Comment on: Measurement units for antibiotic consumption in outpatients. The Journal of antimicrobial chemotherapy, 69(12)
Abrams S, Hens N. (2014). Modeling individual heterogeneity in the acquisition of recurrent infections: an application to parvovirus B19. Biostatistics (Oxford, England), 16(1)
Le Blon D, Hoornaert C, Daans J, Santermans E, Hens N, Goossens H, Berneman Z, Ponsaerts P. (2014). Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain. Immunology and cell biology, 92(8)
Lernout T, Theeten H, Hens N, Braeckman T, Roelants M, Hoppenbrouwers K, Van Damme P. (2014). Timeliness of infant vaccination and factors related with delay in Flanders, Belgium. Vaccine, 32(2)
Hens N, Calatayud L, Kurkela S, Tamme T, Wallinga J. (2012). Robust reconstruction and analysis of outbreak data: influenza A(H1N1)v transmission in a school-based population. American journal of epidemiology, 176(3)
Willem L, Van Kerckhove K, Chao DL, Hens N, Beutels P. (2012). A nice day for an infection? Weather conditions and social contact patterns relevant to influenza transmission. PloS one, 7(11)
Bilcke J, Marais C, Ogunjimi B, Willem L, Hens N, Beutels P. (2012). Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Vaccine, 30(3)
Hens N, Van Ranst M, Aerts M, Robesyn E, Van Damme P, Beutels P. (2011). Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: a multi-country analysis for influenza A/H1N1v 2009. Vaccine, 29(5)
Hens N, Ayele GM, Goeyvaerts N, Aerts M, Mossong J, Edmunds JW, Beutels P. (2009). Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC infectious diseases, (9)
Hens N, Goeyvaerts N, Aerts M, Shkedy Z, Van Damme P, Beutels P. (2009). Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium. BMC infectious diseases, (9)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.